Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

If you’ve ever felt that sudden, overwhelming wave of heat—the telltale sign of a hot flash—you know how disruptive and ...

As I was taking a psyco-social medical history of a 43-year-old woman, I asked, “What is your problem?” She replied, “I can’t sleep at night, I can’t seem to remember anything, my muscles hurt, ...

Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage ...

Postmenopausal women with a history of hormone therapy use have slower biological aging compared to those who never used the ...

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.

New research published in Menopause, the journal of The Menopause Society, found a possible link between severe menopause ...

Sabrina Sweeney For the thousands of women depending on the promise of free hormone replacement therapy (HRT) from this month ...

Medically reviewed by Renita White, MD Perimenopause is the transition period when the female body starts to shift from ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

This article reviews the published literature on the use of venlafaxine, fluoxetine, and paroxetine for the treatment of hot flashes.